Conversely, the serum levels of glucagon-like peptide-1 (GLP-1) (7.74 ± 2.07 vs. 9.06 ± 2.11; p = 0.012) were notably lower in the CAD group than in the non-CAD group. This evidence concerns the gene GCG and coronary artery disorder.